Praxis Precision Medicines (PRAX) Earnings Date & Reports
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
PRAX is expected to report earnings to fall 92.46% to -22 cents per share on March 13
Q4'23
Est.
$-0.22
Q4'24
Missed
by $0.15
Q3'24
Missed
by $0.76
Q2'24
Beat
by $0.57
Q3'23
Beat
by $0.08
The last earnings report on February 28 showed earnings per share of -294 cents, missing the estimate of -278 cents. With 545.09K shares outstanding, the current market capitalization sits at 748.26M.